| Location: | Minnesota |
|---|---|
| Posted: | Mar 17, 2026 |
| Due: | Mar 24, 2026 |
| Agency: | State Government of Minnesota |
| Type of Government: | State & Local |
| Category: |
|
| Solicitation No: | 36880 |
| Publication URL: | To access bid details, please log in. |
This is a single source posting notification; there are no solicitation documents for download. Note this posting is not a Request for Bid (RFB) or Request for Proposal (RFP).
The Minnesota Department of Health Newborn Screening Lab (NBS) intends to enter into a onetime agreement with Qiagen LLC to purchase Qiagen reagents required for the NBS Lab’s assay for Severe Combined Immunodeficiency (SCID), Spinal Muscular Atrophy (SMA), and to validate a new addition to the Newborn Screening testing panel Congenital Cytomegalovirus (CMV). This assay uses the extraction method for our cystic fibrosis (CF) test, which has been previously validated. The NBS Lab has conducted extensive testing of these assay kits to validate our methodology and instrumentation, changing products would be neither time nor cost effective.
If there are any concerns regarding this single source opportunity, contact Matt Griser at matt.griser@state.mn.us by March 24, 2026 at 2:00 PM Central Time. Include the reference number and title of the posting in the subject line. Or you may call the HelpLine at 651.296.2600 (MN Relay Service for persons with speech or hearing disabilities: 711 or 1.800.627.3529).

With GovernmentContracts, you can:
...6.10 Ground Penetration Radar Survey 6.11 Geotechnical Instrumentation 7.0 Transportation Planning...
State Government of Minnesota
Bid Due: 6/25/2026
...; Recommendations 6.10 Ground Penetration Radar Survey 6.11 Geotechnical Instrumentation 7.0...
State Government of Minnesota
Bid Due: 6/25/2026